Munson Healthcare

 

MHC-300x48

Courtney VanHouzen, PharmD
PGY-2 Oncology Resident
Munson Healthcare, Cowell Family Cancer Center
Traverse City, Michigan

Implementation of a Bispecific T-Cell Engager Therapy Program at a Community Cancer Center

Development of this comprehensive bispecific antibody program included policy development; toxicity management; creation of patient and staff education documents; creation of clinician tools like a toxicity scoring and charting tool and an electronic order set that segregates treatment options; and a monitoring system to safely transition patients from inpatient to outpatient care.

Watch Video

Read Article

Implementation of a Bispecific Program at a Community Cancer Center

06-14_Van Houzen_Page_1Munson Healthcare’s Cowell Family Cancer Center won a 2024 ACCC Innovator Award for its bispecific T-cell engager therapy program, which offers a viable alternative to CAR T-cell therapy for patients with relapsed and refractory cancers. Learn how this pharmacist-led program manages unique toxicities with meticulous planning and patient education in this month’s Oncology Issues.
Read Full Article

Read Blog

Implementation of a Bispecific T-Cell Engager Therapy Program at a Community Cancer Center

Van-Houzen-ACCCBuzzACCCBuzz spotlights Munson Healthcare, Cowell Family Cancer Center in Traverse City, MI, one of the recipients of the 2024 ACCC Innovator Award.
Read Full Story